Trial intelligence / Profile preview

IRON-HF

NCT00386126Phase 3Unknown

Sponsor
Hospital de Clínicas de Porto Alegre
Start
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in heart failure (HF) and anemia comparing Iron Sucrose IV, Ferrous sulfate PO and Placebo (3 arms). Primary endpoint: Oxygen maximal consumption at 3 months. Status: unknown.

02

Drugs

iron sucroseferrous sulfate
03

Conditions

heart failure (HF)anemia

Beyond the preview

Go deeper on NCT00386126.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00386126.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call